Cited by

• Therapy of complicated Crohn's disease during pregnancy--an interdisciplinary challenge.

  Seifarth C, Ritz JP, Pohlen U, Kroesen AJ, Siegmund B, Frericks B, Buhr HJ. Seifarth C, et al. Int J Colorectal Dis. 2014 Jun;29(6):645-51. doi: 10.1007/s00384-014-1880-4. Epub 2014 May 4. Int J Colorectal Dis. 2014. PMID: 24793212 Review.
• Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.

  Meserve J, Luo J, Zhu W, Veeravalli N, Bandoli G, Chambers CD, Singh AG, Boland BS, Sandborn WJ, Mahadevan U, Singh S. Meserve J, et al. Gastroenterology. 2021 Jul;161(1):107-115.e3. doi: 10.1053/j.gastro.2021.03.020. Epub 2021 Mar 18. Gastroenterology. 2021. PMID: 33744307 Free PMC article.
• European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

  Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ; European Crohn's and Colitis Organisation. Caprilli R, et al. Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c. Gut. 2006. PMID: 16481630 Free PMC article.
• Mutagenicity of cytostatic drugs in a bacterial system. I. Ames test.

  Marhan J. Marhan J. Folia Microbiol (Praha). 1995;40(5):457-61. doi: 10.1007/BF02814722. Folia Microbiol (Praha). 1995. PMID: 8763144
• The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.

  Nørgård BM, Friedman S, Kjeldsen J, Nielsen J. Nørgård BM, et al. Aliment Pharmacol Ther. 2022 Nov;56(9):1349-1360. doi: 10.1111/apt.17189. Epub 2022 Aug 28. Aliment Pharmacol Ther. 2022. PMID: 36031741 Free PMC article.